SuicideSuicide-CovidNCT05795894
Qualitative Study of Suicidal Recrudescence Among Adolescents in November 2021
An observational study of Suicide and COVID-19, run by Fondation Lenval at 1 site in France.
Trial summary
A qualitative study, combining psychiatric and anthropological perspectives, focused on the lived experiences of patients who had recourse to HPNCL emergencies during the period of November 2021, as well as the experiences and perceptions of those around them - such as their family, teachers or school and nursing… Read more about this study
- Who is it for?
- Ages 13 to 17 yearsHealthy volunteers can take part
- What is being tested?
- STAI-Y, BDI scale and M.I.N.I.Kid
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 10 participants
- Where
- 1 siteFrance
- Study dates
- 12 Jul 2022to Mar 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 13 to 17 years
- All sexes
- Healthy volunteers accepted
- Child
Study population: * The patient who consulted the emergency room during the month of November 2021 * The parent(s) of the study participant * One or more health professionals taking care of the patient * The school attended by the patient who will be questioned about the suicidal problem and Covid-19 in general or not about the patient in particular. * Child welfare professionals (ASE) potentially involved in the care of the study participant
Who may be able to join
- Any patient having consulted in the child psychiatric emergency room of the HPNCL between November 1, 2021 and November 30, 2021 for suicidal thoughts.
- Age between 13 years and 17 years and 11 months
- Good understanding of written and oral French
- Collection of the informed consent of the patient and of one of the two parents or holder of parental authority
Who cannot join
- Inability to comply with the instructions defined and exposed during inclusion
- Refusal of participation by the patient or one of the legal guardians
Trial locations and contacts
1 site in 1 country.
Brigitte REMY, MD contact
France1 site, 1 recruiting
- Recruiting
hôpital Lenval
Nice, 06200
Louise-Emilie DUMAS, MD, 0492030372, Louise-Emilie.dumas@hpu.lenval.com
Brigitte REMY, MD, Brigitte.REMY@hpu.lenval.com
About this study
Official title: Suicidology and Anthropology Research Protocol : Qualitative Study of Suicidal Recrudescence Among Adolescents in November 2021
A qualitative study, combining psychiatric and anthropological perspectives, focused on the lived experiences of patients who had recourse to HPNCL emergencies during the period of November 2021, as well as the experiences and perceptions of those around them - such as their family, teachers or school and nursing staff. This multi-site approach will provide a multidimensional perspective on the experience of individuals and those around them, as well as a triangulation of data.
The hypotheses to explain the increase in the rate of suicidal crisis will be addressed through semi-structured interviews proposed to the participants of the study.
Read the detailed description
Interviews in the presence of two members of the research team (child psychiatrists, psychologists, anthropologists, etc.) will be offered to participants. These interviews will be face-to-face when possible, but can also be done remotely, by teleconsultation, depending on the preferences of the participants.
These interviews will be based on a questionnaire established beforehand evoking the history of mental disorders and the experience of the participant in the study and his entourage of the Covid-19 health crisis.
All information exchanged during these interviews will be made anonymous (data collected and processed as well as the results presented). They will be used exclusively in the context of the study and not communicated to the medical team involved in the patient's care.
The proposed interviews will be carried out separately with:
- The patient who consulted the emergency room during the month of November 2021
- The parent(s) of the study participant
- One or more health professionals taking care of the patient
- The school attended by the patient who will be questioned about the suicidal problem and Covid-19 in general or not about the patient in particular.
- Child welfare professionals (ASE) potentially involved in the care of the study participant.
Questionnaires will also be carried out with patients in order to complete the assessment of their clinical condition at a distance from the psychological crisis:
- Being tested
- STAI-Y, BDI scale, M.I.N.I.Kid, PCL-5
- Keywords
- pediatric
- Medical subject headings
- Suicide, COVID-19
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
STAI-YBehavioural
Situational Anxiety and Trait Anxiety Inventory
BDI scaleBehavioural
- Beck Depression Inventory scale
M.I.N.I.KidBehavioural
Suicidal risk" module of the Mini-International Neuropsychiatric Interview child/adolescent version
PCL-5Behavioural
Post-traumatic Check List Scale
| Study group | Role | What they receive |
|---|---|---|
| patents | Questionnaires Receives: Behavioral: STAI-Y; Behavioral: BDI scale; Behavioral: M.I.N.I.Kid; Behavioral: PCL-5 |
What is being measured
The primary outcome is the main question the study is designed to answer.
Situational Anxiety and Trait Anxiety Inventory
This inventory aims to assess anxiety as a "personality trait" (feelings of apprehension, tension, nervousness and worry that the subject usually feels), and anxiety as a ' "emotional state" linked to a particular situation (feelings of apprehension, tension or nervousness that the subject feels at a specific moment).
This is a questionnaire comprising 20 items for the "state" form and 20 items for the "trait" form. The instruction is to answer "in general, in the usual way" for the "trait" scale and "at the moment" for the "state" scale.
Each score can therefore vary from 20 to 80 with a "very high" anxiety norm when the threshold is > 65, "high" between 56 and 65, "medium" between 46 and 55, "low" between 36 and 45 and "very low" for a score < or = 35.
Measured: at inclusion
Secondary outcomes (3)
Beck Depression Inventory
The Beck Depression Inventory is a diagnostic self-questionnaire allowing a quantitative estimation of the intensity of depressive symptoms in adults and adolescents. It consists of 21 symptom and attitude items, which describe a specific behavioral manifestation of depression, graded from zero to three by a series of four statements reflecting the degree of severity of the symptom. The subject must indicate, among the propositions, the one that best describes how he has felt during the last seven days. The total score varies between 0 (absence of depressive symptoms) and 63. Some authors suggest that in a normal population, a total BDI score greater than 15 is an argument in favor of depression. The results of this scale can also be categorized according to: normal score < 15; mild depression: 10 to 18; moderate depression: 19 to 29; severe depression > 30
Measured: at inclusion
"Suicidal risk" module of the Mini-International Neuropsychiatric Interview child/adolescent
The MINI is a short structured diagnostic interview, jointly developed by psychiatrists and clinicians in the United States and Europe, for DSM IV and CIM 10 psychiatric disorders. It was designed to meet the need for a short structured psychiatric interview for clinical trials and epidemiological studies and for use as a first step in monitoring outcomes in clinical settings. Its very brief "suicide risk" module is sometimes used alone to determine the level of suicide risk. It is composed of 6 binary questions. The level of risk is established according to the number of questions having obtained a positive answer
Measured: at inclusion
Post-traumatic Check List Scale
The questionnaire includes 20 items, each question is to be rated between 1 and 5 depending on the intensity and frequency of symptoms during the previous month. The maximum score is 80. A threshold of 33 to 38 is proposed for screening for post-traumatic stress disorder (PTSD)
Measured: at inclusion
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Apr 2023
- Study start12 Jul 2022
- Primary completionMar 2024 (estimated)
- Study completionMar 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SuicideStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 10 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Fondation Lenval
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Louise-Emilie DUMAS, MD, Principal investigator, Fondation Lenval
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05795894
- Sponsor's protocol ID
- 22-HPNCL-07
- Acronym
- Suicide-Covid
- Status last verified
- Jan 2024
- First submitted
- 21 Mar 2023
- Last updated
- 29 Jan 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 29 Jan 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Suicidology and Anthropology Research Protocol : Qualitative Study of Suicidal Recrudescence Among Adolescents in November 2021
- ClinicalTrials.gov ID
- NCT05795894
- Acronym / sponsor ID
- Suicide-Covid / 22-HPNCL-07
- Keywords
- pediatric
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 10 participants (estimated)
- Lead sponsor
- Fondation LenvalUniversity, hospital or other
- Study start
- 12 Jul 2022 (actual)
- Primary completion
- Mar 2024 (estimated)
- Study completion
- Mar 2024 (estimated)
- First posted
- 3 Apr 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A qualitative study, combining psychiatric and anthropological perspectives, focused on the lived experiences of patients who had recourse to HPNCL emergencies during the period of November 2021, as well as the experiences and perceptions of those around them - such as their family, teachers or school and nursing staff. This multi-site approach will provide a multidimensional perspective on the experience of individuals and those around them, as well as a triangulation of data.
The hypotheses to explain the increase in the rate of suicidal crisis will be addressed through semi-structured interviews proposed to the participants of the study.
Detailed description
Interviews in the presence of two members of the research team (child psychiatrists, psychologists, anthropologists, etc.) will be offered to participants. These interviews will be face-to-face when possible, but can also be done remotely, by teleconsultation, depending on the preferences of the participants.
These interviews will be based on a questionnaire established beforehand evoking the history of mental disorders and the experience of the participant in the study and his entourage of the Covid-19 health crisis.
All information exchanged during these interviews will be made anonymous (data collected and processed as well as the results presented). They will be used exclusively in the context of the study and not communicated to the medical team involved in the patient's care.
The proposed interviews will be carried out separately with:
- The patient who consulted the emergency room during the month of November 2021
- The parent(s) of the study participant
- One or more health professionals taking care of the patient
- The school attended by the patient who will be questioned about the suicidal problem and Covid-19 in general or not about the patient in particular.
- Child welfare professionals (ASE) potentially involved in the care of the study participant.
Questionnaires will also be carried out with patients in order to complete the assessment of their clinical condition at a distance from the psychological crisis:
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| patents | – | Behavioral: STAI-Y, Behavioral: BDI scale, Behavioral: M.I.N.I.Kid, Behavioral: PCL-5Questionnaires |
Who may qualify
- Ages
- 13 to 17 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
- Study population
- * The patient who consulted the emergency room during the month of November 2021 * The parent(s) of the study participant * One or more health professionals taking care of the patient * The school attended by the patient who will be questioned about the suicidal problem and Covid-19 in general or not about the patient in particular. * Child welfare professionals (ASE) potentially involved in the care of the study participant
Key inclusion criteria (4 listed)
- Any patient having consulted in the child psychiatric emergency room of the HPNCL between November 1, 2021 and November 30, 2021 for suicidal thoughts.
- Age between 13 years and 17 years and 11 months
- Good understanding of written and oral French
- Collection of the informed consent of the patient and of one of the two parents or holder of parental authority
Key exclusion criteria (2 listed)
- Inability to comply with the instructions defined and exposed during inclusion
- Refusal of participation by the patient or one of the legal guardians
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| STAI-YSituational Anxiety and Trait Anxiety Inventory | Behavioural | patents |
| BDI scale• Beck Depression Inventory scale | Behavioural | patents |
| M.I.N.I.KidSuicidal risk" module of the Mini-International Neuropsychiatric Interview child/adolescent version | Behavioural | patents |
| PCL-5Post-traumatic Check List Scale | Behavioural | patents |
Primary outcome
Situational Anxiety and Trait Anxiety Inventory
Time frame: at inclusion
This inventory aims to assess anxiety as a "personality trait" (feelings of apprehension, tension, nervousness and worry that the subject usually feels), and anxiety as a ' "emotional state" linked to a particular situation (feelings of apprehension, tension or nervousness that the subject feels at a specific moment). This is a questionnaire comprising 20 items for the "state" form and 20 items for the "trait" form. The instruction is to answer "in general, in the usual way" for the "trait" scale and "at the moment" for the "state" scale. Each score can therefore vary from 20 to 80 with a "very high" anxiety norm when the threshold is > 65, "high" between 56 and 65, "medium" between 46 and 55, "low" between 36 and 45 and "very low" for a score < or = 35.
3 secondary outcomes
Beck Depression Inventory
Time frame: at inclusion
"Suicidal risk" module of the Mini-International Neuropsychiatric Interview child/adolescent
Time frame: at inclusion
Post-traumatic Check List Scale
Time frame: at inclusion
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Jan 2024.
Related trials for Suicide
Not yet recruiting
A Pre-post Study of a Lethal Means Safety Planning Intervention for Youth at Elevated Suicide Risk in the Emergency Department
Suicidal Ideas, Suicidal Ideation
RecruitingObservational study
Student Precarity and Psychiatry
Depressive Disorder, Major, Generalized Anxiety Disorder
Not yet recruiting
SERENE Low-Intensity Focused Ultrasound for Cognitive Control
Suicidal Ideation, Cognitive Control
Not yet recruiting
A MRT to Optimize a JITAI for Alcohol Craving and Suicide Ideation
Alcohol Use Disorder (AUD), Suicide Ideation
Enrolling by invitation
Pilot Study of a Modified Safety Planning Intervention for Elementary School-Aged Children - Main Study
Suicidal Ideation, Suicidal Behaviors
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Brigitte REMY, MD contact
Louise-Emilie DUMAS, MD principal investigator
Fondation Lenval
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Suicide and COVID-19, run by Fondation Lenval at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 29 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Louise-Emilie DUMAS, MD (0492030372, Louise-Emilie.dumas@hpu.lenval.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Situational Anxiety and Trait Anxiety Inventory (time frame: at inclusion). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jan 2024.